Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nippon Carbon, 2% Increase in Ordinary Profit for The Current Fiscal Year
5302 Nippon Carbon Co. , Ltd. 【J-GAAP】
Earnings ReportNippon Carbon Co. , Ltd. <5302> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 decreased 5.9% from the previous period to 6.69 billion yen. In the fiscal year ending December 2025, the profit is expected to grow by 1.6% to 6.8 billion yen. This will be the fifth consecutive term of revenue growth.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit decreased to 1.82 billion yen, a 27.4% decrease compared to the same period last year. The operating profit margin decreased from 20.6% in the same period last year to 15.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 35,799 | 4,791 | 5,042 | 3,194 | 289.2 | 200 | Feb 10, 2023 | J-GAAP |
Dec, 2023 | 37,867 | 6,573 | 7,115 | 4,050 | 366.8 | 200 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 37,956 | 6,319 | 6,692 | 4,078 | 369.0 | 200 | Feb 10, 2025 | J-GAAP |
YoY | +0.2% | -3.9% | -5.9% | +0.7% | +0.6% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 43,000 | 7,100 | 7,200 | 4,100 | 370.8 | 200 | Feb 9, 2024 | J-GAAP |
Dec, 2024 Results | 37,956 | 6,319 | 6,692 | 4,078 | 369.0 | 200 | Feb 10, 2025 | J-GAAP |
Revision Rate | -11.7% | -11.0% | -7.1% | -0.5% | -0.5% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 18,800 | 3,393 | 3,775 | 2,292 | 207.5 | 100 | Aug 9, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 20,000 | 3,000 | 3,000 | 1,800 | 162.8 | 100 | Feb 10, 2025 | J-GAAP |
YoY | +6.4% | -11.6% | -20.5% | -21.5% | -21.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 37,867 | 6,573 | 7,115 | 4,050 | 366.8 | 200 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 37,956 | 6,319 | 6,692 | 4,078 | 369.0 | 200 | Feb 10, 2025 | J-GAAP |
Dec, 2025 Guidance | 40,000 | 6,500 | 6,800 | 4,100 | 370.8 | 200 | Feb 10, 2025 | J-GAAP |
YoY | +5.4% | +2.9% | +1.6% | +0.5% | +0.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 11,027 | 2,275 | 2,517 | 1,419 | 128.5 | 20.6 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 8,438 | 1,621 | 1,760 | 969 | 87.8 | 19.2 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 10,362 | 1,772 | 2,015 | 1,323 | 119.8 | 17.1 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 8,623 | 1,348 | 1,090 | 595 | 53.9 | 15.6 | Nov 11, 2024 | J-GAAP |
Oct - Dec, 2024 | 10,533 | 1,578 | 1,827 | 1,191 | 107.8 | 15.0 | Feb 10, 2025 | J-GAAP |
YoY | -4.5% | -30.6% | -27.4% | -16.1% | -16.1% |
Related Articles
DAITO KOUN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Oct-Dec Ordinary Profit Increases by 25%
CELM Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%, Oct-Dec Ordinary Profit Decreases by 10%
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
NISSAN TOKYO SALES, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 9%
Human Creation, Oct-Dec (1Q) Ordinary Profit Increases by 53%
MINATO HOLDINGS , Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 49%
Maruichi Steel Tube, The Current Fiscal Year Net Income Revised Upward to an Unexpected 2% Increase
SAYLOR ADVERTISING, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Widens, Oct-Dec Ordinary Profit Decreases by 90%